"This launch, at its core, is about taking our existing agents SDK and making it so it's compatible with all of these sandbox providers," Karan Sharma, who works on OpenAI's product team, told TechCrunch.
Novo Nordisk plans to deploy advanced artificial intelligence capabilities to analyze complex datasets, identify promising drug candidates, and reduce the time required to move from research to patient.
We are firing on all cylinders to establish this as a scaled distribution channel. The pivot to Amazon enables OpenAI to develop systems that can operate reliably over time and across complex business processes.